Juggling the impact of disease, treatment, study participation on patients’ lives

Inger Nijhof, MD, PhD 

 St. Antonius Hospital, Hematologist,Department of Internal Medicine, The Netherlands

We all realize myeloma has a major impact on patients’ lives. But also treatments and participating in clinical studies can have a major influence. To what extent is this being discussed with patients?

This e-learning module zooms in on juggling the impact of the disease, treatment and/or participation in clinical studies on the quality of life.

Approximate time: 1 hour

Module 3: Juggling the impact of disease, treatment, study participation on patients’ lives

Accredited for 1 CME point

Start module 3

Scientific Expert Panel

Inger Nijhof, MD, PhD 


St. Antonius Hospital,

Department of Internal Medicine,

The Netherlands

Fredrik Schjesvold, MD, PhD 


Oslo Myeloma Center,

Department of Hematology,


Isabelle Vande Broek, MD, PhD 


Vitaz, Sint-Niklaas,

Department of Oncology & Hematology,


Agoston Gyula Szabo , MD 


Righospitalet Copenhagen,

Department of Hematology,


Ville Varmavuo, MD, PhD 

Chief Medical Officer in Education,


Internal Medicine,


Prof. Xavier Leleu, MD, PhD 


Academic Hospital of Poitiers,


Valdas Peceliunas, MD 


Vilnius University Hospital Santaros Klinikos,

Department of Hematology,


Share this e-learning with your colleagues


Accreditation for this e-learning has been granted for 1 point per module by:

European Accreditation Council for Continuing Medical Education (EACCME) & Nederlandse Internisten Vereniging (NIV)

Obtain CME points

To obtain CME points, you must answer at least 70% of the questions in the final test correctly. If you have a lower score, you can retake the final test twice more. You can pause the e-learning and then resume where you paused.

Clinical cases

Throughout the e-learning challenging clinical cases from daily practice are being presented by the International Expert Panel.

See all clinical cases